Muutke küpsiste eelistusi

Adverse Effects and Therapeutic Potential of Psychedelic Medicines: A Guide to the Risks and Rewards of Using Psychedelics in Therapy [Kõva köide]

  • Formaat: Hardback, 256 pages, kõrgus x laius x paksus: 229x152x25 mm, kaal: 438 g
  • Ilmumisaeg: 04-Jun-2026
  • Kirjastus: Park Street Press,U.S.
  • ISBN-13: 9798888500781
Teised raamatud teemal:
  • Kõva köide
  • Hind: 38,09 €
  • See raamat ei ole veel ilmunud. Raamatu kohalejõudmiseks kulub orienteeruvalt 3-4 nädalat peale raamatu väljaandmist.
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
Adverse Effects and Therapeutic Potential of Psychedelic Medicines: A Guide to the Risks and Rewards of Using Psychedelics in TherapySuurem pilt
  • Formaat: Hardback, 256 pages, kõrgus x laius x paksus: 229x152x25 mm, kaal: 438 g
  • Ilmumisaeg: 04-Jun-2026
  • Kirjastus: Park Street Press,U.S.
  • ISBN-13: 9798888500781
Teised raamatud teemal:
Püsilink: https://www.kriso.ee/db/9798888500781.html
A guide to informed and responsible psychedelic use

Draws on current research, interviews, and case studies to detail the risks and benefits of psychedelics like LSD, psilocybin, MDMA, ketamine, and mescaline

Explores the short- and long-term effects of psychedelics, looking at heart rate, blood pressure, and markers of mental health

Includes in-depth profiles of psychedelics, considering their chemical composition, effects, safety considerations, and legal status

The psychedelic renaissance has been opening new therapeutic modalities in Western medicine. With the potential to reduce our reliance on pharmaceuticals and improve overall well-being, the use of psychedelics has yielded promising results. However, the increased acceptance and use of these age-old medicines should also be approached with caution and full awareness.

Clinical psychologist Richard Louis Miller provides a balanced analysis of the risks and benefits of psychedelics to ensure their responsible use. He comprehensively details the rewards and potential complications of substances like LSD, psilocybin, ayahuasca, DMT, MDMA, and ketamine to provide thorough risk profiles and a working guide for psychedelic-informed therapy.

Drawing on the latest research, interviews with practitioners, and case studies, Dr. Miller considers physiological effects like nausea, altered heart rate, and blood pressure changes, along with mental effects such as anxiety, reality distortion, and mood disorders often associated with a bad trip. He also includes an extensive, in-depth Psychedelic Clinical Profiles guide to the 13 most commonly used psychedelic substances, detailing their chemical composition, safety considerations, and legal status.

As psychedelics become more accepted as medicines, it is important that we become fully knowledgeable about their effects. By revealing the benefits and risks, this book is a key resource in the ethical and responsible use of psychedelics.

Arvustused

Dr. Richard Louis Miller is a true elder and wisdom keeper of the psychedelic community, and his credentials come honestly, through hard-won experience. In this book, he continues his role as an educator by sharing his knowledge of both the perils and the promise of psychedelic substances. The reader will find valuable advice on how to avoid pitfalls while realizing the maximum benefits from the thoughtful and safe use of these remarkable medicines. * Dennis J. McKenna, PhD, director and founder of Mckenna Academy of Natural Philosophy and author of * I am pleased to recommend this book, which is the latest in Richards series on psychedelic medicines. Putting forth the adverse effects of these substances in readable form contributes to their understanding and separates psychedelic scientists from those who would cover over, or even hide, negative effects of pharmaceuticals. * Robin Carhart-Harris, PhD, Ralph Metzner Distinguished Professor of Neurology, Psychiatry and Behavi * Comprehensive, well-researched, and balanceda valuable cache of current knowledge for anyone who seeks to comprehend the psychedelic frontier. * William A. Richards, PhD, author of Sacred Knowledge * There is a resurgence of interest in the therapeutic potential of psychedelics in a culture lacking a shared understanding of their risks and true potential benefits, which presents many questions and complex challenges for individuals and for therapists and medical practitioners. Fortunately, in this book Dr. Miller shares his perspectives about these challenges, based on his long and deep experience in this area. Along with specific pharmacological information about a range of psychedelics, he addresses the more complex challenges stemming from the fundamental mismatch between the usual medical model of understanding pharmacology and the reality that psychedelics catalyze change through intense experiences that often require integration long after the drug has been cleared from the body. * Michael Mithoefer, MD, MDMA researcher * In this remarkably frank and transparent guidebook, Dr. Richard Louis Miller distills the knowledge from his 50 years of professional self-experimentation and his extensive exploration of the findings of other therapists, scholars, and researchers. The result is a concise guide balancing the perils and benefits of encounters with a spectrum of psychedelic substances. * Mariavittoria Mangini, PhD, FNP, investigator of psychedelic-assisted therapies *

PROLOGUE The Space Between Hope and Caution,
Promise and Peril

PART 1
The Promises and Pitfalls of the
Psychedelic Renaissance

ONE Full Transparency

TWO Understanding Psychedelic Substances

PART 2
Acute Adverse Effects

THREE Mental Adverse Effects

FOUR Somatic Challenges

PART 3
Prolonged Adverse Effects

FIVE Prolonged Perceptual Changes

SIX Long-Term Psychological and
Existential Disturbances

SEVEN The Enigma of Recovered Memories

PART 4
The Crucial Need for
Professional Standards

EIGHT Abuse of Patient Trust in Psychedelic Therapy

NINE Ramifications of an Unsafe Environment

TEN Harm ReductionFrom Theory to Practice

ELEVEN Integration

TWELVE The Way Forward

Resources for Psychedelic Safety, Research,
and Integration

Guide to Psychedelic Clinical Profiles

2C-B (2,5-dimethoxy-4-bromophenethylamine)

5-APB (5-(2-Aminopropyl)benzofuran)

5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine)

Ayahuasca

DMT (N,N-Dimethyltryptamine)

DOM (2,5-Dimethoxy-4-methylamphetamine)

Ibogaine

Ketamine (2-(2-chlorophenyl)-2-(methylamino)
cyclohexanone)

LSD (Lysergic Acid Diethylamide)

MDMA (3,4-Methylenedioxymethamphetamine)

Mescaline (3,4,5-trimethoxyphenethylamine)

Psilocybin Mushrooms

Salvia divinorum / Salvinorin A

References

Index
Dr. Richard Louis Miller, MA, PhD, has been a clinical psychologist for more than 65 years. He is host of the internet radio broadcast show Mind Body Health & Politics. He founded the internationally acclaimed Cokenders Alcohol and Drug Program and is the creator and chief clinician of the Health Sanctuary at Wilbur Hot Springs in California. Dr. Miller has been a faculty member at the University of Michigan and Stanford University, an advisor on the Presidents Commission on Mental Health, a founding board member of the Gestalt Institute of San Francisco, and a member of the national board of directors for the Marijuana Policy Project. He lives in Fort Bragg and Wilbur Hot Springs, California.